Replimune Group, Inc. (REPL)
7.61
-0.29
(-3.67%)
USD |
NASDAQ |
Mar 12, 16:00
7.51
-0.10
(-1.31%)
After-Hours: 20:00
Replimune Group Shareholders Equity (Quarterly) : 210.54M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Sarepta Therapeutics, Inc. | 1.141B |
| REGENXBIO, Inc. | 102.73M |
| Bristol Myers Squibb Co. | 18.47B |
| Mirum Pharmaceuticals, Inc. | 314.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 333.59M |
| Total Liabilities (Quarterly) | 123.05M |
| Debt to Equity Ratio | 0.3626 |
| Current Ratio | 5.597 |
| Net Debt Paydown Yield | -0.01% |